Is mood chemistry?
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
The chemical hypothesis of depression suggests that mood disorders are caused by a chemical imbalance in the brain, which can be corrected by antidepressant drugs. However, recent evidence indicates that problems in information processing within neural networks, rather than changes in chemical balance, might underlie depression, and that antidepressant drugs induce plastic changes in neuronal connectivity, which gradually lead to improvements in neuronal information processing and recovery of mood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that problems of information processing within neuronal networks associated with neuromorphological changes underlie depression (Castrén, 2005).”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Castrén, 2005
In the citing paper
“Conversely, when neuroplasticity is enhanced (e.g., by treatment), synaptic contacts increase, enhancing adaptability by allowing activity-dependent competition to stabilize the neural structures that best represent internal and external conditions 24-26 .”
From Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model (2020) · cites this paper as [24]
In the citing paper
“The iPlasticity concept proposes that psychedelics may induce a permissive state for neuroplasticity that requires the stabilization of new connections guided by network activity produced by experience (Castrén, 2005).”
From Psychedelics and Neural Plasticity: Therapeutic Implications (2022) · cites this paper as Castrén, 2005
Citations
Cites
The brainweb: phase synchronization and large-scale integration
Varela, F., Lachaux, J.-P., Rodriguez, E., & Martinerie, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067550 · Cited by 4,761
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Synaptic Activity and the Construction of Cortical Circuits
Katz, L. C., & Shatz, C. J. (1996) · Science · doi:10.1126/science.274.5290.1133 · Cited by 3,048
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Cited by
Items 101–200 of 576
Brain-derived neurotrophic factor and suicide pathogenesis
Dwivedi, Y. (2010) · Annals of Medicine · doi:10.3109/07853890903485730 · Cited by 115
Mice with altered BDNF signaling as models for mood disorders and antidepressant effects
Lindholm, J. S. O., & Castrén, E. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00143 · Cited by 114
Réus, G. Z., Stringari, R. B., Kirsch, T. R., Fries, G. R., Kapczinski, F. P., Roesler, R., & Quevedo, J. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.11.013 · Cited by 118
Differential effects of antidepressant drugs on mTOR signalling in rat hippocampal neurons
Park, S. W., Lee, J. G., Seo, M. K., Lee, C. H., Cho, H. Y., Lee, B. J., Seol, W., & Kim, Y. H. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000534 · Cited by 111
Plasticity in the adult brain: lessons from the visual system
Spolidoro, M., Sale, A., Berardi, N., & Maffei, L. (2009) · Experimental Brain Research · doi:10.1007/s00221-008-1509-3 · Cited by 111
Ruggiero, R. N., Rossignoli, M. T., Marques, D. B., de Sousa, B. M., Romcy-Pereira, R. N., Lopes-Aguiar, C., & Leite, J. P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.732360 · Cited by 111
The dynamics of the stress neuromatrix
Sousa, N. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.196 · Cited by 107
Gilabert‐Juan, J., Varea, E., Guirado, R., Blasco‐Ibáñez, J. M., Crespo, C., & Nácher, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.09.032 · Cited by 115
NCAM in Neuropsychiatric and Neurodegenerative Disorders
Brennaman, L. H., & Maness, P. F. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1170-4_19 · Cited by 114
Harmine and Imipramine Promote Antioxidant Activities in Prefrontal Cortex and Hippocampus
Réus, G. Z., Stringari, R. B., de Souza, B., Petronilho, F., Dal-Pizzol, F., Hallak, J. E., Zuardi, A. W., Crippa, J. A., & Quevedo, J. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.5.13109 · Cited by 110
5-HT and depression: is the glass half-full?
Sharp, T., & Cowen, P. J. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.02.003 · Cited by 153
Stress and glucocorticoid footprints in the brain—The path from depression to Alzheimer's disease
Sotiropoulos, I., Cerqueira, J. J., Catania, C., Takashima, A., Sousa, N., & Almeida, O. F. X. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.007 · Cited by 100
Sartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B., Brand, U., Fleischhacker, W., Goodwin, G., Grunze, H., Knapp, M., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 98
Cirulli, F., Berry, A., Bonsignore, L. T., Capone, F., D’Andrea, I., Aloe, L., Branchi, I., & Alleva, E. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.008 · Cited by 105
Bdnf gene is a downstream target of Nurr1 transcription factor in rat midbrain neurons in vitro
Volpicelli, F., Caiazzo, M., Greco, D., Consales, C., Leone, L., Perrone‐Capano, C., D’Amato, L. C., & Porzio, U. D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04494.x · Cited by 99
Dentate gyrus neurogenesis and depression
Sahay, A., Drew, M. R., & Hen, R. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63038-6 · Cited by 116
Chen, W., Lai, Y.-S., Lin, S.-H., Lu, K., Lin, Y., Panyod, S., Ho, C., & Sheen, L. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.02.001 · Cited by 105
Alme, M. N., Wibrand, K., Dagestad, G., & Bramham, C. R. (2007) · Neural Plasticity · doi:10.1155/2007/26496 · Cited by 103
Guirado, R., Perez-Rando, M., Sanchez-Matarredona, D., Castrén, E., & Nacher, J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000406 · Cited by 103
Krugers (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00024 · Cited by 102
Neuronal nitric oxide synthase and affective disorders
Zhou, Q., Zhu, X., Nemes, A. D., & Zhu, D. (2018) · IBRO Reports · doi:10.1016/j.ibror.2018.11.004 · Cited by 106
Effects of Chronic Social Isolation on Wistar Rat Behavior and Brain Plasticity Markers
Djordjevic, J., Djordjevic, A. D., Adžić, M., & Radojcic, M. B. (2012) · Neuropsychobiology · doi:10.1159/000338605 · Cited by 113
Breuillaud, L., Rossetti, C., Meylan, E. M., Mérinat, C., Halfon, O., Magistretti, P. J., & Cardinaux, J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.011 · Cited by 111
Emiliano, A. B., Cruz, T., Pannoni, V., & Fudge, J. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301206 · Cited by 110
Serotonergic Modulation of Intrinsic Functional Connectivity
Schaefer, A., Burmann, I., Regenthal, R., Arélin, K., Barth, C., Pampel, A., Villringer, A., Margulies, D. S., & Sacher, J. (2014) · Current Biology · doi:10.1016/j.cub.2014.08.024 · Cited by 106
Fortunato, J. J., Réus, G. Z., Kirsch, T. R., Stringari, R. B., Fries, G. R., Kapczinski, F., Hallak, J. E., Zuardi, A. W., Crippa, J. A., & Quevedo, J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0451-2 · Cited by 98
NGF, Brain and Behavioral Plasticity
Berry, A., Bindocci, E., & Alleva, E. (2012) · Neural Plasticity · doi:10.1155/2012/784040 · Cited by 104
Röthlisberger, P., Gasse, C., & Hollenstein, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112430 · Cited by 99
Role of phosphodiesterase 5 in synaptic plasticity and memory
Puzzo, D., Sapienza, S., Arancio, O., & Palmeri, A. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2447 · Cited by 105
Ohira, K., Takeuchi, R., Iwanaga, T., & Miyakawa, T. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-43 · Cited by 96
Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex
Varea, E., Blasco-Ibáñez, J. M., Gómez-Climent, M. Á., Castillo-Gómez, E., Crespo, C., Martínez-Guijarro, F. J., & Nácher, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301183 · Cited by 96
Wilkinson, S. T., Holtzheimer, P. E., Gao, S., Kirwin, D. S., & Price, R. B. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.09.004 · Cited by 95
Polysialic acid in brain development and synaptic plasticity
Hildebrandt, H., & Dityatev, A. (2013) · Topics in current chemistry · doi:10.1007/128_2013_446 · Cited by 94
“Dysfunction of inhibitory neurotransmission and connectivity in the prefrontal cortex (PFC) are involved in the pathogenesis of schizophrenia and major depression [281-283].”
Resilience and vulnerability: a neurobiological perspective
Karatsoreos, I. N., & McEwen, B. S. (2013) · F1000Prime Reports · doi:10.12703/p5-13 · Cited by 84
Ludka, F. K., Zomkowski, A. D. E., Cunha, M. P., Dal-Cim, T., Zeni, A. L. B., Rodrigues, A. L. S., & Tasca, C. I. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.005 · Cited by 92
Schizophrenia and the Scaffolded Self
Krueger, J. W. (2018) · Topoi · doi:10.1007/s11245-018-9547-3 · Cited by 101
Baur, V., Brühl, A. B., Herwig, U., Eberle, T., Rufer, M., Delsignore, A., Jäncke, L., & Hänggi, J. (2013) · Human Brain Mapping · doi:10.1002/hbm.21447 · Cited by 88
Drzyzga, Ł. R., Marcinowska, A., & Obuchowicz, E. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.03.009 · Cited by 97
Neuropeptides in depression: Role of VGF
Thakker-Varia, S., & Alder, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.006 · Cited by 86
Imaging genetics of mood disorders
Scharinger, C., Rabl, U., Sitte, H. H., & Pezawas, L. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.019 · Cited by 84
Synaptic plasticity model of therapeutic sleep deprivation in major depression
Wolf, E., Kühn, M., Normann, C., Mainberger, F., Maier, J. G., Maywald, S., Bredl, A., Klöppel, S., Biber, K. P. H., van Calker, D., et al. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.11.003 · Cited by 90
Branchi, I., Karpova, N. N., D’Andrea, I., Castrén, E., & Alleva, E. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.038 · Cited by 87
Réus, G. Z., Stringari, R. B., Ribeiro, K. F., Luft, T., Abelaira, H. M., Fries, G. R., Aguiar, B. W., Kapczinski, F., Hallak, J. E., Zuardi, A. W., et al. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00579.x · Cited by 86
Non-pharmacological factors that determine drug use and addiction
Ahmed, S. H., Badiani, A., Miczek, K. A., & Müller, C. P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.08.015 · Cited by 89
Kozicz, T., Ouwens, D. T. W. M., Faludi, G., Palkovits, M., & Roubos, E. W. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.12.050 · Cited by 93
Serotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memory
Hartley, C. A., McKenna, M. C., Salman, R., Holmes, A., Casey, B. J., Phelps, E. A., & Glatt, C. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202044109 · Cited by 82
Li, X.-Y., Zhang, S.-Y., Hong, Y.-Z., Chen, Z.-G., Long, Y., Yuan, D.-H., Zhao, J., Tang, S., Wang, H., & Hong, H. (2024) · Neuron · doi:10.1016/j.neuron.2024.02.019 · Cited by 85
Psychedelics and Neural Plasticity: Therapeutic Implications
Grieco, S. F., Castrén, E., Knudsen, G. M., Kwan, A. C., Olson, D. E., Zuo, Y., Holmes, T. C., & Xu, X. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.1121-22.2022 · Cited by 82
“The iPlasticity concept proposes that psychedelics may induce a permissive state for neuroplasticity that requires the stabilization of new connections guided by network activity produced by experience (Castrén, 2005).”
Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy
Lepow, L., Morishita, H., & Yehuda, R. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.710004 · Cited by 85
Lin, S.-H., Chou, M.-L., Chen, W.-C., Lai, Y.-S., Lu, K., Hao, C.-W., & Sheen, L. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.09.018 · Cited by 81
Hochstrasser, T., Ullrich, C., Sperner‐Unterweger, B., & Humpel, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.070 · Cited by 89
Psychiatric vulnerability: Suggestions from animal models and role of neurotrophins
Alleva, E., & Francia, N. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.09.004 · Cited by 95
Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review
Pompili, M., Serafini, G., Innamorati, M., Venturini, P., Fusar-Poli, P., Sher, L., Amore, M., & Girardi, P. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.765593 · Cited by 78
Characterization of the sleep EEG in acutely depressed men using detrended fluctuation analysis
Leistedt, S., Dumont, M., Lanquart, J. ‐., Jurysta, F., & Linkowski, P. (2007) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.01.003 · Cited by 87
iPlasticity: Induced juvenile‐like plasticity in the adult brain as a mechanism of antidepressants
Umemori, J., Winkel, F., Didio, G., Llach Pou, M., & Castrén, E. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12683 · Cited by 80
The cannabinoid CB 1 receptor and the endocannabinoid anandamide: possible antidepressant targets
Bambico, F. R., & Gobbi, G. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.11.1347 · Cited by 80
Desipramine Reduces Stress-Activated Dynorphin Expression and CREB Phosphorylation in NAc Tissue
Chartoff, E. H., Papadopoulou, M., MacDonald, M. L., Parsegian, A., Potter, D. N., Konradi, C. L., & Carlezon, W. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051417 · Cited by 89
Astrocyte dysfunction drives abnormal resting-state functional connectivity in depression
Liu, J., Mo, J., Wang, X., An, Z., Zhang, S., Zhang, C.-Y., Yi, P., Leong, A. T. L., Ren, J., Chen, L.-Y., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo2098 · Cited by 82
Yee, B. K., Zhu, S., Mohammed, A. H., & Feldon, J. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0548-9 · Cited by 80
Åberg, E., Losada, A. F., Sjöholm, L. K., Forsell, Y., & Lavebratt, C. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.009 · Cited by 83
Nácher, J., Guirado, R., & Castillo-Gómez, E. (2013) · Neurochemical Research · doi:10.1007/s11064-013-0977-4 · Cited by 82
A Model for the Involvement of Neural Cell Adhesion Molecules in Stress-Related Mood Disorders
Sandi, C., & Bisaz, R. (2007) · Neuroendocrinology · doi:10.1159/000101535 · Cited by 75
Larsen, M. H., Hay‐Schmidt, A., Rønn, L. C. B., & Mikkelsen, J. D. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.08.050 · Cited by 82
Lu, Y., Wang, C., Xue, Z., Li, C., Zhang, J., Zhao, X., Liu, A., Wang, Q., & Zhou, W. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu110 · Cited by 75
O’Leary, O. F., Wu, X., & Ċastrén, E. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.09.015 · Cited by 79
Leuchter, A. F., Hunter, A. M., Krantz, D. E., & Cook, I. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12742 · Cited by 71
Phillips, C. (2017) · Neural Plasticity · doi:10.1155/2017/7014146 · Cited by 65
Noda, Y., Zomorrodi, R., Vila-Rodriguez, F., Downar, J., Farzan, F., Cash, R. F. H., Rajji, T. K., Daskalakis, Z. J., & Blumberger, D. M. (2018) · Depression and Anxiety · doi:10.1002/da.22738 · Cited by 68
New generation antidepressants for depression in children and adolescents: a network meta-analysis
Hetrick, S. E., Meader, N., Bailey, A. P., Badcock, P. B., Moller, C. I., Cox, G., Merry, S., & McKenzie, J. E. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013674 · Cited by 73
Glutamate normalization with ECT treatment response in major depression
Zhang, J., Narr, K. L., Woods, R. P., Phillips, O. R., Alger, J. R., & Espinoza, R. T. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.46 · Cited by 70
Weiss, F., Magnesa, A., Gambini, M., Gurrieri, R., Annuzzi, E., Elefante, C., Perugi, G., & Marazziti, D. (2025) · Brain Sciences · doi:10.3390/brainsci15020117 · Cited by 74
Molteni, R., Calabrese, F., Pisoni, S., Gabriel, C., Mocaer, E., Racagni, G., & Riva, M. A. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903447659 · Cited by 70
Petschner, P., Gonda, X., Baksa, D., Eszlari, N., Trivaks, M., Juhasz, G., & Bagdy, G. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2017.09.049 · Cited by 67
Pinna, G. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833d8ba0 · Cited by 71
Guirado, R., Sanchez-Matarredona, D., Varea, E., Crespo, C., Blasco-Ibáñez, J. M., & Nacher, J. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-5 · Cited by 70
Guidotti, G., Calabrese, F., Auletta, F., Olivier, J., Racagni, G., Homberg, J. R., & Riva, M. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.252 · Cited by 79
Lenkey, N., Károly, R., Kiss, J., Szász, B. K., Vizi, E. S., & Mike, Á. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026419 · Cited by 71
Bramham, C. R. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(07)63025-8 · Cited by 69
Fink, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00001-2 · Cited by 72
Wang, W., Yang, L., Xue, Z., Li, C., Wang, C.-N., Zhao, X., Zhang, J., Wei, X., Chen, X., Cui, W., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.025 · Cited by 73
Rief, W., Barsky, A. J., Bingel, U., Doering, B. K., Schwarting, R., Wöhr, M., & Schweiger, U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.008 · Cited by 67
Chen, J., Lei, C., Li, X., Wu, Q., Liu, C., Ma, Q., & Chen, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.925514 · Cited by 72
Stress Controversies: Post-Traumatic Stress Disorder, Hippocampal Volume, Gastroduodenal Ulceration*
Fink, G. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02089.x · Cited by 63
Wu, X., & Ċastrén, E. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.023 · Cited by 71
Calabrese, F., Molteni, R., Gabriel, C., Mocaër, E., Racagni, G., & Riva, M. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2129-8 · Cited by 69
Fear Extinction as a Model for Synaptic Plasticity in Major Depressive Disorder
Kuhn, M., Höger, N., Feige, B., Blechert, J., Normann, C., & Nissen, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115280 · Cited by 66
Haghighi, M., Khodakarami, S., Jahangard, L., Ahmadpanah, M., Bajoghli, H., Holsboer-Trachsler, E., & Brand, S. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.018 · Cited by 65
Kiss, J., Szász, B. K., Fodor, L., Mike, Á., Lenkey, N., Kurkó, D., Nagy, J., & Vizi, E. S. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.005 · Cited by 72
Sawamoto, A., Okuyama, S., Yamamoto, K., Amakura, Y., Yoshimura, M., Nakajima, M., & Furukawa, Y. (2016) · Molecules · doi:10.3390/molecules21040541 · Cited by 68
The Embodied and Situated Nature of Moods
Colombetti, G. (2017) · Philosophia · doi:10.1007/s11406-017-9817-0 · Cited by 72
Brain, networks, depression, and more
Leistedt, S., & Linkowski, P. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.10.011 · Cited by 69
Ahmadpanah, M., Akbari, T., Akhondi, A., Haghighi, M., Jahangard, L., Bahmani, D. S., Bajoghli, H., Holsboer‐Trachsler, E., & Brand, S. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.07.030 · Cited by 66
The Role of Serotonin in Fear Learning and Memory: A Systematic Review of Human Studies
Tortora, F., Hadipour, A. L., Battaglia, S., Falzone, A., Avenanti, A., & Vicario, C. M. (2023) · Brain Sciences · doi:10.3390/brainsci13081197 · Cited by 66
A population‐based association study of candidate genes for depression and sleep disturbance
Utge, S., Soronen, P., Partonen, T., Loukola, A., Kronholm, E., Pirkola, S., Nyman, E., Porkka‐Heiskanen, T., & Paunio, T. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31002 · Cited by 62
Association of low serum BDNF with depression in patients with Parkinson's disease
Wang, Y., Liu, H., Du, X., Zhang, Y., Yin, G., Zhang, B., Soares, J. C., & Zhang, X. Y. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.05.012 · Cited by 68
Sales, A. J., & Joca, S. R. L. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.40 · Cited by 62
“The conventional antidepressants available act via monoaminergic mechanisms, mainly by inhibiting monoamine reuptake or its metabolism, thus increasing monoamine availability at the synaptic cleft (4,36,37).”
BackgroundMethodInfluentialVarea, E., Castillo-Gómez, E., Gómez‐Climent, M. Á., Blasco‐Ibáñez, J. M., Crespo, C., Martinez-Guijarro, F. J., & Nácher, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.01.001 · Cited by 68
Tamási, V., Petschner, P., Adori, C., Kirilly, E., Ando, R. D., Tothfalusi, L., Juhasz, G., & Bagdy, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113662 · Cited by 61
Bjørnebekk, A., Mathé, A. A., & Brené, S. (2010) · Hippocampus · doi:10.1002/hipo.20683 · Cited by 61
Bambico, F. R., & Belzung, C. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_234 · Cited by 68
Metadata
- Authors
- Castrén, E.
- Venue
- Nature Reviews Neuroscience
- Published
- 2005-03
- Volume
- 6
- Issue
- 3
- Pages
- 241-246
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W1985237413
- Cited by
- 563
- References
- 66
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 17 · 2023: 14 · 2022: 17 · 2021: 21 · 2020: 24 · 2019: 14 · 2018: 27 · 2017: 24 · 2016: 33 · 2015: 20 · 2014: 27 · 2013: 33 · 2012: 42
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- depression, mood disorders, antidepressants, neural information processing, artificial neural networks, neuroplasticity, neuronal connectivity, mood recovery
- MeSH terms
- Affect, Animals, Brain Chemistry, Humans, Models, Neurological, Biogenic Monoamines, Neural Networks, Computer, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.